Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2018 Publisher: AFT Pharmaceuticals Ltd, PO BOX 33203, Takapuna, Auckland, Email: customer.service@aftpharm.com
PROBENECID-AFT, Probenecid 500 mg film coated tablets.
| Pharmaceutical Form |
|---|
|
Probenecid-AFT tablets are yellow capsule-shaped, film coated tablets, bisected on one side and plain on the other. |
Each tablet contains 500 mg Probenecid.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Probenecid |
Probenecid is a uricosuric and renal tubular blocking agent. It inhibits the tubular reabsorption of urate, thus increasing the urinary excretion of uric acid and decreasing serum urate levels. Effective uricosuria reduces the miscible urate pool, retards urate deposition, and promotes resorption of urate deposits. |
| List of Excipients |
|---|
|
Maize starch |
Probenecid Tablet 500 mg is packed in Milky White 100 cc HDPE Bottles & Milky White 38 mm HDPE caps with induction wad, which is labeled with Printed Sticker Labels.
Silica Gel Bags is used in packing as a preventive measure to absorb excess of moisture.
AFT Pharmaceuticals Ltd, PO BOX 33203, Takapuna, Auckland, Email: customer.service@aftpharm.com
04/02/2010
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
